Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients — Katia Donadello (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients
Article
2013
en
Authors
+6 more
KD
Katia Donadello
SS
Sabino Scolletta
FT
Fabio Silvio Taccone
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2020
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) As a Biomarker of Renal Outcomes in AL Amyloidosis
Efstathios Kastritis
,
Ioannis Papassotiriou
,
Foteini Theodorakakou
,
Alexandra Margeli
,
Anastasia Barzteliotou
,
Eleni Tsiligkeridou
,
Amalia Andreatou
,
Despina Fotiou
,
Magdalini Migkou
,
Nikolaos Kanellias
,
Ioanna Dialoupi
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Maria Gavriatopoulou
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2013
suPAR as a prognostic biomarker in critically ill patients
Katia Donadello
,
Sabino Scolletta
,
FS Taccone
,
Cecilia Covajes
,
Cristina Santonocito
,
Delia Cortés
,
Daiva Gražulytė
,
Leonardo Gottin
,
Jean Louis Vincent
Article
2016
Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
Abdullah Genç
,
Tevfik Kalelioğlu
,
Nesrin Karamustafalıoğlu
,
Akif Tasdemir
,
Esra Genç
,
Mustafa Akkuş
,
Murat Emül
Article
2019
Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis
Jiwon M. Lee
,
Jae Won Yang
,
Andreas Kronbichler
,
Michael Eisenhut
,
Gaeun Kim
,
Keum Hwa Lee
,
Jae Il Shin
Article
2019
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)
Eftathios Kastritis
,
Ioannis Papassotiriou
,
Μαρία Ρούσσου
,
Maria Gavriatopoulou
,
Mantzou Aimilia
,
Erasmia Psimenou
,
Smaragdi Marinaki
,
Charikleia Gakiopoulou
,
Alexandra Margeli
,
Nikolaos Kanellias
,
Magdalini Migkou
,
Despina Fotiou
,
Ioannis Ntanasis‐Stathopoulos
,
Gerasimos-Petros Papassotiriou
,
Αριστέα-Μαρία Παπανώτα
,
Evangelos Terpos
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.